Cargando…
4067 Cancer-related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction
OBJECTIVES/GOALS: Combined androgen deprivation therapy (ADT) and radiation therapy (RT) is the standard of care treatment for non-metastatic prostate cancer (NMPC). Despite the efficacy, treatment-related symptoms including fatigue greatly reduce the quality of life of cancer patients. The goal of...
Autores principales: | Liwang, Josephine K., Feng, Li Rebekah, Wolff, Brian, Regan, Jeniece, Alshawi, Sarah, Saligan, Leorey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823204/ http://dx.doi.org/10.1017/cts.2020.373 |
Ejemplares similares
-
Cancer-related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction
por: Feng, Li Rebekah, et al.
Publicado: (2020) -
Cancer-related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction
por: Feng, Li Rebekah, et al.
Publicado: (2020) -
4313 Impaired Natural Killer Cell Function May Be Associated with Cancer-related Fatigue
por: Regan, Jeniece, et al.
Publicado: (2020) -
Steroid Hormone Biosynthesis Metabolism Is Associated With Fatigue Related to Androgen Deprivation Therapy for Prostate Cancer
por: Feng, Li Rebekah, et al.
Publicado: (2021) -
Brain-derived neurotrophic factor polymorphism Val66Met protects against cancer-related fatigue
por: Feng, Li Rebekah, et al.
Publicado: (2020)